Select Publications
Journal articles
2009, 'Ro 60 functions as a receptor for β2-glycoprotein I on apoptotic cells', Arthritis Care & Research, 60, pp. 860 - 869
,2009, 'Ro60 Functions as a receptor for B2-glycoprotein I on apoptotic cells', Arthritis Care & Research, 60, pp. 985 - 994
,2008, 'Factors Influencing Outcome in Cellulitis Admitted to Hospital and the Role of the Infectious Disease Physician', INTERNATIONAL JOURNAL OF INFECTIOUS DISEASES, 12, pp. E240 - E240, http://dx.doi.org/10.1016/j.ijid.2008.05.599
,2008, 'Beta
2008, 'beta 2-glycoprotein I inhibits vascular endothelial growth factor and basic fibroblast growth factor induced angiogenesis through its amino terminal domain', Journal of Thrombosis and Haemostasis, 6, pp. 1215 - 1223, http://dx.doi.org/10.1111/j.1538-7836.2008.03000.x
,2008, 'Beta2- Glycoprotein I Protects Thrombin from Inhibition by Heparin Cofactor II', Arthritis Care & Research, 58, pp. 1146 - 1155
,2008, 'The antiphospholipid syndrome: molecular and diagnostic aspects', INTERNATIONAL JOURNAL OF LABORATORY HEMATOLOGY, 30, pp. 18 - 19
,2008, 'The Diacylglcerol-dependent translocation of ras guanine nucleotide -releasing protein 4 inside a human mast cell line results in substantional phenotypic changes ,including expressions of interluken 13 recepter a2', The Journal of Biological Chemistry, 283, pp. 1610 - 1621
,2007, 'Beta
2007, 'Anti-beta(2)-glycoprotein I antibodies in complex with beta(2)-glycoprotein I can activate platelets via glycoprotein Ib-IX-V', Clinical and Experimental Rheumatology, 25, pp. 159 - 160
,2007, 'APL targets and mediated effects: PL-binding proteins B2GPI', Clinical and Experimental Rheumatology, 25, pp. 123 - 123
,2007, 'Beta(2)-glycoprotein I binds thrombin via exosite I and exosite II Anti-beta(2)-glycoprotein I antibodies potentiate the inhibitory effect of beta(2)-glycoprotein I on thrombin-mediated factor XIa generation', Arthritis Care & Research, 56, pp. 605 - 613
,2007, 'Current concepts on the pathogenesis of the antiphospholipid syndrome', Blood, 109, pp. 422 - 430
,2007, 'Ras guanine nucleotide releasing protein 4 (RasGRP4) dependent pathways and genes that reversibly control the development, phenotype, and function of human mast cells (MCs)', Journal of Allergy and Clinical Immunology, 119, pp. S50 - S50
,2006, 'Anti-β
2006, 'Anti-Beta2-Glycoprotein I Antibodies in Complex With Beta2-Glycoprotein I Can Activate Platelets in a Dysregulated Manner Via Glycoprotein Ib-IX-V', Arthritis Care & Research, 54, pp. 2558 - 2567
,2006, 'Human and mouse mast cells use the Tetraspanin CD9 as an alternate Interleukin 16 receptor', Blood, 107, pp. 135 - 142
,2006, 'International consensus statement on an update of the classification criteria for definite antiphospholipid syndrome (APS)', Journal of Thrombosis and Haemostasis, 4, pp. 295 - 306
,2006, 'International consensus statement on an update of the classification criteria for definite antiphospholipid syndrome (APS)', Journal of Thrombosis and Haemostasis, 4, pp. 295 - 306
,2005, 'A case of desquamating rash associated with methadone use', Medical Journal of Australia, 182, pp. 76 - 77
,2005, 'Domain V of B2-Glycoprotein I Binds Factor XI/XIa and Is Cleaved of Lys317-Thr318', The Journal of Biological Chemistry, 280, pp. 907 - 912
,2005, 'Importance of C-Reactive Protein in Regulating Monocyte Tissue Factor Expresion in Patients with Inflammatory Rhumatic Diseases', The Journal of Rheumatology, 32, pp. 1224 - 1231
,2005, 'Multifocal cutaneous mucormycosis complicating polymicrobial wound infections in a tsunami survivor from Sri Lanka', Lancet, 365, pp. 876 - 878
,2005, 'Pathogenic role of anTi-beta 2-glycoprotein I in antiphospholipid-associated with fetal loss: characterisation of beta 2-glycoprotein I binding to trophoblast cells and functional effects of anti-beta 2-gylprotein I antiobodies in vitro', Annals of the Rheumatic Diseases, 64, pp. 462 - 467
,2005, 'Urokinase-type plasminogen activator is a preferred substrate of the human epithelium serine protease tryptase /PRSS22', Blood, 105, pp. 3893 - 3901
,2004, 'Labile zinc and zinc transporter ZnT4 in mast cell granules: Role in regulation NF-KB translocation', JOURNAL OF IMMUNOLOGY, 172, pp. 7750 - 7760, http://dx.doi.org/10.4049/jimmunol.172.12.7750
,2004, 'β
2004, 'Laboratory tests for the antiphospholipid syndrome: Current concepts', Pathology, 36, pp. 129 - 138, http://dx.doi.org/10.1080/00313020410001671966
,2004, 'Anti-beta(2) glycoprotein I antibodies potentiate the inhibitory effects of beta(2)glycoprotein I on the activation of FXI by FIIa: Effect of clipped beta(2) glycoprotein I', Thrombosis Research, 114, pp. 608 - 608
,2004, 'B-2-glycoprotein I binds factor XI by its C-terminal domain and inhibits its activation by thrombin and factor XIIA. Plasmin cleavage of B-2-glycoprotein I abolishes its inhibition of factor XIIA activation of factor XI', Thrombosis Research, 114, pp. 608 - 609
,2004, 'B2Glycoprotein I binds Factor XI and inhibits its activation by thrombin and Factor XIIa. Loss of Inhibition by Clipped B2Glycoprotein I.', Proceedings of the National Academy of Sciences of the United States of America, 101, pp. 3939 - 3944
,2004, 'Beta 2-Glycoprotein I-function in health and disease', Thrombosis Research, 114, pp. 335 - 346
,2004, 'Beta-2 glycoprotein I and its role in antiphospholipid syndrome-lessons from knockout mice', Clinical Immunology, 112, pp. 136 - 143
,2004, 'Effect of B2Glycoprotein I null mutation on reproductive outcome and antiphospholipid antibody-mediated pregnancy pathology in mice', Molecular Human Reproduction, pp. 1 - 8
,2004, 'Effect of beta(2)-glycoprotein I null mutation on reproductive outcome and antiphospholipid antibody-mediated pregnancy pathology in mice', Thrombosis Research, 114, pp. 608 - 608
,2004, 'Effect of beta(2)-glycoprotein I null mutation on reproductive outcomea and antiphospholipid antibody-mediated pregnancy pathology in mice', Molecular Human Reproduction, 10, pp. 409 - 416
,2004, 'Labile zinc and zinc transporter ZnT4 in mast cell granules: role in regulation of caspase activation and NF-kappaB translocation', Journal of Immunology, 172, pp. 7750 - 7760
,2004, 'Laboratory tests for the antiphospholipid syndrome', Pathology, 36, pp. 129 - 138
,2004, 'No correlations between anti-endothelial cell and anti phospholipid antibodies in a cohort of 176 leprosy patients', Thrombosis Research, 114, pp. 611 - 611
,2004, 'Urokinase-type plasminogen activator is a preferred substrate of thehuman epithelium serine protease tryptase epsilon/PRSS22', Federation of American Societies for Experimantal Biology Journal, 18, pp. A793 - A793
,2003, 'Anti-β
2003, 'Anti-β
2003, 'Anti-.2-glycoprotein I antibodies and the antiphospholipid syndrome', Autoimmunity Reviews, 2, pp. 229 - 234
,2003, 'Anti-B2-glycoprotein I autoantibodiese require an antigen density threshold, consistent with divalent binding', Lupus, 12, pp. 37 - 45
,2003, 'Cardiac disease in the antiphospholipid syndrome: recommendations for treatment. Committee consensus report', Lupus, 12, pp. 518 - 523
,2003, 'Hemopoietic Cells with Features of the Mast Cell and Basophil Lineages and their Potential Role in Allergy', Current Drug Targets, 2, pp. 293 - 302
,2003, 'MCs/Basophils in Human Blood', ACI International, 15, pp. 11 - 16
,2003, 'MCs/Basophils in human Blood - What are they and how did they get there?', Allergy and Clinical Immunology International, 15, pp. 11 - 17
,2002, 'Biochemical and functional characterization of human transmembrane tryptase (TMT)/tryptase γ: TMT is an exocytosed mast cell protease that induces airway hyperresponsiveness in vivo via an interleukin-13/interleukin-4 receptor α/signal transducer and activator of transcription (STAT) 6-dependent pathway', Journal of Biological Chemistry, 277, pp. 41906 - 41915, http://dx.doi.org/10.1074/jbc.M205868200
,2002, 'Heparin inhibits the binding of β2-glycoprotein I to phospholipids and promotes the plasmin-mediated inactivation of this blood protein. Elucidation of the consequences of the two biological events in patients with the anti-phospholipid syndrome', Journal of Biological Chemistry, 277, pp. 2644 - 2649, http://dx.doi.org/10.1074/jbc.M110176200
,